Skip to content

Xencor XNCR Common Stock

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
Janux Therapeutics logo
Janux TherapeuticsJANX
$60K+1.7%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$816.53M+3.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$2.42B+65.8%
Absci Corporation logo
Absci CorporationABSI
$15K+15.4%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's common stock?
Xencor (XNCR) reported common stock of $741K in Q1 2026.
How has Xencor's common stock changed year-over-year?
Xencor's common stock increased by 4.1% year-over-year, from $712K to $741K.
What is the long-term trend for Xencor's common stock?
Over 5 years (2020 to 2025), Xencor's common stock has grown at a 4.4% compound annual growth rate (CAGR), from $580K to $718K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).